| Dr Alan Josue Romero, MD | |
|
6606 Lbj Fwy, Suite 200, Dallas, TX 75240 | |
| (972) 715-5000 | |
| (972) 715-9976 |
| Full Name | Dr Alan Josue Romero |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 18 Years |
| Location | 6606 Lbj Fwy, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104004548 | NPI | - | NPPES |
| P01410280 | Other | TX | RR |
| 8EQ712 | Other | TX | BCBS |
| 220665803 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | N6979 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Harris Methodist Hurst-euless-bedford | Bedford, TX | Hospital |
| Texas Health Harris Methodist Hospital Southlake | Southlake, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| U S Anesthesia Partners Of Texas, Pa | 7315850351 | 2379 |
News Archive
Interferon (IFN) responses are one of the first defenses the body mounts against viral infections, and research has shown that it plays a role controlling viral replication.
While the Los Angeles Times reports on the challenges of helping patients who struggle with physical and mental illnesses, the Boston Globe reports on a creative approach to reduce hospital readmissions.
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
› Verified 5 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Interferon (IFN) responses are one of the first defenses the body mounts against viral infections, and research has shown that it plays a role controlling viral replication.
While the Los Angeles Times reports on the challenges of helping patients who struggle with physical and mental illnesses, the Boston Globe reports on a creative approach to reduce hospital readmissions.
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
› Verified 5 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Interferon (IFN) responses are one of the first defenses the body mounts against viral infections, and research has shown that it plays a role controlling viral replication.
While the Los Angeles Times reports on the challenges of helping patients who struggle with physical and mental illnesses, the Boston Globe reports on a creative approach to reduce hospital readmissions.
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Josue Romero, MD Po Box 840853, Dallas, TX 75284-0853 Ph: (972) 715-5000 | Dr Alan Josue Romero, MD 6606 Lbj Fwy, Suite 200, Dallas, TX 75240 Ph: (972) 715-5000 |
News Archive
Interferon (IFN) responses are one of the first defenses the body mounts against viral infections, and research has shown that it plays a role controlling viral replication.
While the Los Angeles Times reports on the challenges of helping patients who struggle with physical and mental illnesses, the Boston Globe reports on a creative approach to reduce hospital readmissions.
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
A record 47% year-over-year sales increase for Q1, 2011 compared to the same period in 2010 was announced today by Centinel Spine, Inc., innovator and a market leader in the Integrated Interbody Fusion™ spine medical device space.
› Verified 5 days ago
Lee M. Lunsford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-8000 | |
Dr. Stephanie C Jones, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9374 | |
Dr. Alfredo Ruben Lopez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 Fax: 972-715-9976 | |
Dr. Elvis Tsang, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12222 Merit Dr Ste 600, Dallas, TX 75251 Phone: 972-715-5000 Fax: 972-715-9976 | |
Dr. Christopher D Lecheminant, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 | |
Dr. Mihir N Rane, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3625 N Hall St Ste 800, Dallas, TX 75219 Phone: 214-252-3500 | |
Lisa Gu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-6400 |